How the Body's Opioid Peptide System Drives Alcohol Addiction

The three opioid peptide families (endorphins, enkephalins, dynorphins) each play distinct roles in alcohol's rewarding effects, with mu and delta receptors promoting and kappa receptors opposing alcohol reward.

Herz, A·Psychopharmacology·1997·Moderate EvidenceReview
RPEP-00410ReviewModerate Evidence1997RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Mu and delta opioid receptors mediate alcohol's rewarding properties while kappa receptors oppose them, with all three endogenous opioid peptide families playing distinct roles in addiction.

Key Numbers

How They Did This

Comprehensive review of preclinical and clinical evidence on opioid receptor subtypes and their endogenous peptide ligands in alcohol reward, craving, and addiction.

Why This Research Matters

Understanding which opioid receptors drive alcohol reward vs. aversion could enable more targeted treatments with fewer side effects than broad opioid blockade.

The Bigger Picture

This review consolidated the scientific basis for naltrexone's FDA approval for alcohol dependence and pointed toward future receptor-specific treatments.

What This Study Doesn't Tell Us

Review article; some claims based on animal data. Individual variation in opioid system genetics affects treatment response.

Questions This Raises

  • ?Would kappa receptor agonists reduce alcohol craving without the side effects of broad opioid blockade?
  • ?Can genetic differences in opioid peptide production predict alcohol addiction risk?

Trust & Context

Key Stat:
Receptor-specific addiction roles Mu and delta receptors drive alcohol reward while kappa receptors oppose it — each with distinct endogenous peptide mediators
Evidence Grade:
Moderate evidence from a comprehensive review covering animal and clinical studies, supporting naltrexone's established clinical use.
Study Age:
Published in 1997, shortly after naltrexone's approval for alcohol dependence. The opioid-alcohol connection has been extensively validated since.
Original Title:
Endogenous opioid systems and alcohol addiction.
Published In:
Psychopharmacology, 129(2), 99-111 (1997)
Authors:
Herz, A(14)
Database ID:
RPEP-00410

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

How does alcohol affect the opioid system?

Alcohol stimulates the release of endorphins and enkephalins, which activate mu and delta opioid receptors in the brain's reward center. This opioid-mediated pleasure reinforces drinking behavior and can drive addiction.

How does naltrexone help with alcohol addiction?

Naltrexone blocks opioid receptors, preventing alcohol from triggering the opioid-mediated pleasure response. Without the reward, the urge to drink diminishes. This study's receptor-specific findings suggest even more targeted treatments may be possible.

Read More on RethinkPeptides

Cite This Study

RPEP-00410·https://rethinkpeptides.com/research/RPEP-00410

APA

Herz, A. (1997). Endogenous opioid systems and alcohol addiction.. Psychopharmacology, 129(2), 99-111.

MLA

Herz, A. "Endogenous opioid systems and alcohol addiction.." Psychopharmacology, 1997.

RethinkPeptides

RethinkPeptides Research Database. "Endogenous opioid systems and alcohol addiction." RPEP-00410. Retrieved from https://rethinkpeptides.com/research/herz-1997-endogenous-opioid-systems-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.